Multimodal imaging enables risk-adapted early melanoma diagnosis by integrating dermoscopy, OCT, in vivo RCM, ex vivo RCM, and LC-OCT. These technologies provide complementary architectural, cellular, and perioperative information, supporting improved diagnostic precision while reducing unnecessary excisions in equivocal melanocytic lesions.
No takes yet. Share an insight, caveat, or question.
Deußing et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: